Subtyping of Non-Small Cell Lung Carcinomas in Bronchoscopic Biopsies: A Tertiary Care Centre Experience
Introduction: The advent of promising targeted therapies against specific subtypes of Non-small Cell Lung Carcinoma (NSCLC) has made it mandatory for the pathologists to subclassify NSCLC into its subtypes, along with saving tissue for molecular studies and work closely with the radiologists and the...
Main Authors: | Mihir Mohan Vaidya, Sharada R Rane, Shaila C Puranik |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2018-11-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/12211/36515_210718_36515_CE[Ra1]_F(SL)_PF1(AB_SHU)_PFA(SHU)_PB(AB_SHU)_PN(SHU).pdf |
Similar Items
-
Diagnostic Value of Immunohistochemistry Panel of P63, CK5/6, TTF1, NapsinA in the Diagnosis of Adenocarcinoma and Squamous Cell Carcinoma of Lung
by: Tahereh Mohsenian Sisakht, et al.
Published: (2020-07-01) -
Comparative Characteristics of Napsin A, TTF 1 and EGFR Mutation Expression in Mucinous Lung Cell Carcinomas
by: Genova Sylvia N., et al.
Published: (2017-06-01) -
Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype?
by: Fabiola Del Carlo Bernardi, et al.
Published: (2018-10-01) -
Utility of Napsin-A in diagnosis of non-small cell lung carcinomas and its addition with thyroid transcription factor-1 (TTF-1) in small biopsies of lung: Does it help in morphologically challenging situations?
by: Richa Ranjan, et al.
Published: (2021-01-01) -
IMP3 can predict aggressive behaviour of lung adenocarcinoma
by: Beljan Perak Renata, et al.
Published: (2012-11-01)